For the investigation of MET-related therapeutics, however, only Jafarnejad et al. have developed a systems biology-type model that described HGF/MET signaling in cancer and simulated different pathway interventions at the in vitro level (Jafarnejad et al., 2019). Here, HGF is linked to cancer.